Business
Medical Marijuana, Inc. Names Caroline Heinz and Raul Elizalde Co-CEOs of Subsidiary HempMeds®, Appoints Todd Morrow to Chief Information Officer
Medical Marijuana, Inc. Names Caroline Heinz and Raul Elizalde Co-CEOs of Subsidiary HempMeds®, Appoints Todd Morrow to Chief Information Officer.
About this update from Medical Marijuana, Inc.
[{"type":"text","content":"\n\n\n\nMedical Marijuana, Inc. Names Caroline Heinz and Raul Elizalde Co-CEOs of Subsidiary HempMeds®, Appoints Todd Morrow to Chief Information Officer\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMedical Marijuana, Inc. Names Caroline Heinz and Raul Elizalde Co-CEOs of Subsidiary HempMeds®, Appoints Todd Morrow to Chief Information Officer\nPR Newswire\nSAN DIEGO, May 7, 2020\n\n\n\nSAN DIEGO, May 7, 2020 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the \"Company\"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that it has named Caroline Heinz and Raul Elizalde co-CEOs of its subsidiary HempMeds®.\n\"It's been a humbling experience to see the drive and dedication that both of these professionals have showcased over the years,\" said Medical Marijuana, Inc. CEO Dr. Stuart Titus. \"We saw our Latin American sales explode during 2018 and 2019, especially in Brazil and Mexico. We are optimistic about how Raul and Caroline are adding their leadership to the global HempMeds brand.\"\nCaroline Heinz, formerly the Vice President of HempMeds® Brasil, joined the Company in 2014 when Brazil's National Health Surveillance Agency (Anvisa) approved the import of HempMeds'® Real Scientific Hemp Oil™ as the first-ever legally imported hemp-derived cannabidiol (CBD) product. With the help of numerous families using CBD, Heinz helped pass legislation to get the Brazilian government to subsidize CBD for several indications. She was also able to grow the Company's sales in Brazil, successfully established two HempMeds® Brasil offices, created a network of Brazilian doctors and medical professionals, and has partnered with research organizations to study the Company's CBD oil for safety and efficacy.\nRaul Elizalde, formerly the President of HempMeds® Mexico and Latin American operations, joined the Company in June 2017. He was an active medical cannabis advocate prior to joini...